Company: ICUI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000883984-25-000007
Chunk: 89

Company: ICU MEDICAL INC/DE
Filing Date: 2025-02-27
Form: 10-K
Item: Item 15
Chunk 89
---
1,696 $— $11,064 Warranty and return reserve - accounts receivable$5,863 $1,627 $15 $— $7,505 Warranty and return reserve - inventory/accrued(3)$50,819 $20,290 $(13,313)$— $57,796 Deferred tax asset valuation allowance$11,166 $— $(2,714)$— $8,452 For the year ended December 31, 2024:    Allowance for doubtful accounts(4)$11,064 $5,800 $(5,394)$— $11,470 Warranty and return reserve - accounts receivable$7,505 $(1,441)$806 $— $6,870 Warranty and return reserve - inventory/accrued(5)$57,796 $2,571 $(18,146)$— $42,221 Deferred tax asset valuation allowance(6)$8,452 $78,592 $3,906 $— $90,950 

______________________________________________

(1) Includes an acquired balance of $3.8 million related to the Smiths Medical acquisition.

(2) Includes an acquired balance of $55.2 million in short-term and long-term accrued warranty reserve related to the Smiths Medical acquisition.

(3Additional charges to expense were primarily related to additional field corrective actions identified and initiated during the period related to the Smiths Medical business FDA warning letter  (See Note: 16 Commitments and Contingencies in our accompanying consolidated financial statements).

(4) The charged to other accounts includes a $2.0 million reclassification to assets held for sale related to the IV Solutions business (See Note 4: Assets held For Sale in our accompanying consolidated financial statements).

(5) Primarily includes payments for expenses related to our field corrective actions.

(6) Primarily relates to valuation allowance against certain U.S. federal and state deferred tax assets (See Note 14:  Income Taxes in our accompanying consolidated financial statements).

121